Investec Wealth and Investment fund research specialist Anthony Leatham is to leave the company for a role at broker Peel Hunt.
Woodford Investment Management (WIM) is to take a 15% performance fee of any excess returns above the 10% annual return target on its Patient Capital investment trust.
The Gabelli Value Plus trust is to list on the London Stock Exchange on 19 February after a fundraising period described by Numis analysts as "a considerable success".
Fund research and ratings group RSMR is now rating investment trusts in response to adviser demand.
Accessing three ‘closed’ strategies via investment trusts
Woodford Investment Management (WIM) is seeking to raise an initial £200m for the launch of the Woodford Patient Capital investment trust, a portfolio of 50-100 quoted and unquoted businesses.
Canaccord Genuity has criticised 'complacent' investment trust boards in a new report, suggesting they must modernise if they are to compete effectively in the funds market.
Twenty years of change and innovation